The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.99

Today's change+0.06 +0.46%
Updated August 25 10:14 AM EDT. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.99

Today's change+0.06 +0.46%
Updated August 25 10:14 AM EDT. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc up (U.S.)$0.06

Allscripts Healthcare Solutions Inc is up today by (U.S.)$0.06 or 0.46% to (U.S.)$12.99. Over the last five days, shares have gained 2.28%, but are down 15.54% for the last year to date. Shares have underperformed the S&P 500 by 16.73% during the last year.

Key company metrics

  • Open(U.S.) $12.93
  • Previous close(U.S.) $12.93
  • High(U.S.) $13.08
  • Low(U.S.) $12.89
  • Bid / Ask(U.S.) $12.99 / (U.S.) $13.00
  • YTD % change-15.54%
  • Volume213,554
  • Average volume (10-day)2,282,282
  • Average volume (1-month)2,493,103
  • Average volume (3-month)2,355,172
  • 52-week range(U.S.) $11.47 to (U.S.) $15.78
  • Beta1.08
  • Trailing P/E884.28×
  • P/E 1 year forward21.99×
  • Forward PEG1.36×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.02
Updated August 25 10:14 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.78%

Based on its net profit margin of 0.78%, Allscripts Healthcare Solutions Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue387346346354
Total other revenue--------
Total revenue387346346354
Gross profit167152154153
Total cost of revenue220194192201
Total operating expense368334323346
Selling / general / administrative95847991
Research & development48474648
Depreciation / amortization5446
Interest expense (income), net operating--------
Unusual expense (income)0510
Other operating expenses, total--------
Operating income1912239
Interest income (expense), net non-operating-12-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-3315-1
Income after tax-2216-5
Income tax, total-11-24
Net income-2216-5
Total adjustments to net income-8------
Net income before extra. items-2216-5
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10216-5
Inc. avail. to common incl. extra. items-10216-5
Diluted net income-10216-5
Dilution adjustment00----
Diluted weighted average shares187191189189
Diluted EPS excluding extraordinary itemsvalue per share-0.050.010.09-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.050.030.09-0.03